Professional and Business Buyer Verification Notice

Version 2026-08-04-v1 · Effective August 4, 2026 · Issued by ALEVA TECHNOLOGIES INC.

1. Why ALEVA verifies buyers

ALEVA sells professional ultrasound and medical-technology products. It may verify identity, organization, authority, credentials, destination, intended use, import or resale role, and product eligibility to protect patients, comply with product labeling and law, prevent diversion, and manage fraud and sanctions risk.

2. United States and Canada

For a United States or Canadian billing or delivery destination, ALEVA requires a manual buyer-eligibility decision before enabling payment for a regulated product. ALEVA may also require verification for any other destination or transaction.

Potentially eligible categories include: a practitioner licensed for the relevant scope; a credentialed sonographer or technologist operating under any required authority or supervision; a hospital, clinic, imaging center, or healthcare facility; an authorized reseller, distributor, or importer; and an approved manufacturer or research institution.

3. Evidence

ALEVA may request a professional licence, ARDMS or comparable credential, facility record, accreditation, business registration, reseller certificate, purchase order, FDA-related establishment or device information, Health Canada MDEL or MDL information where applicable, authorized-contact confirmation, or an end-use statement.

ARDMS and similar credentials are professional certifications, not a universal licence to purchase or use every device. They may support eligibility review only when consistent with product labeling, professional scope, facility policies, supervision requirements, and applicable law.

4. Product authorization is separate

Buyer verification does not replace authorization for the specific device. Products sold into Canada must have the required Health Canada authorization, including a valid Medical Device Licence for Class II, III, or IV devices; importers and distributors may require an MDEL. In the United States, prescription-device labeling and FDA marketing requirements continue to apply. ALEVA may limit a quotation or refuse shipment if product-market authorization is not established.

5. Review and decision

Submission does not create a right to approval, pricing, payment, shipment, credit, or tax treatment. ALEVA may verify information with issuers or public registries, request more information, set conditions, approve only a particular product or transaction, expire an approval, reject a request, or suspend a prior approval. Automated upload never completes approval; an authorized ALEVA reviewer must record the decision.

6. Customer obligations

The customer must provide complete and current information, use documents only with authority, notify ALEVA of changes, follow labeling and training requirements, prevent unauthorized access or diversion, maintain records required for complaints or recalls, and comply with professional, facility, import, resale, export, sanctions, and tax obligations.

7. Privacy and sensitive information

Verification records are handled under the Privacy Policy. Do not submit patient information, payment-card data, account passwords, private keys, or unrelated sensitive records. ALEVA may retain verification and decision evidence for compliance, fraud prevention, audit, limitation, and dispute purposes.

8. Regulatory references

See the FDA’s prescription-device labeling information and Health Canada’s medical-device licensing overview. Product classification and transaction facts control over this general summary.